Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AMRUTANJAN.NS
HoldFallen FavouriteAmrutanjan Health Care Limited · Healthcare · India · $153M · Avg Vol: $705K/d
53
StockRankGet insider-trade alerts
Q
71
V
37
M
40
P/E (TTM)
27.0x
ROE
15.6%
D/E
0.0x
Dividend %
0.9%
COMPANY DESCRIPTION
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 3.8B | 4.2B | 4.5B | 5.0B | 9.9% | 5.1B |
| EPS (INR) | 13.65 | 15.50 | 17.58 | 20.03 | 13.6% | 18.67 |
| Shares | 29.2M | 28.9M | 28.9M | 28.9M | -1.0% | 28.9M |
| Debt | 9.1M | 17.3M | 20.8M | 17.8M | 25.0% | 17.8M |
| Equity | 2.9B | 2.9B | 3.3B | 3.7B | 8.4% | — |
| Op CF | 201.8M | 279.1M | 509.0M | 359.7M | 21.2% | 359.7M |
| Inv CF | -24.8M | 191.7M | -309.7M | -212.3M | — | — |
| Fin CF | -149.9M | -482.7M | -134.9M | -136.2M | — | — |
Loading 1Y...
PRICE (1Y)-2.5%
SMA 50SMA 200
Close
$5.30
RSI (14)
52.4
52W High
$8.26
From 52W High
0.6%
SCORE BREAKDOWN
Quality
71
ROIC
19.0%89.5
ROE
15.6%83.2
GP/Assets
51.5%87.7
Op. Margin
2.2%46.6
FCF/Assets
-3.7%37.2
Piotroski
549.3
Int. Cover
50.0x89.2
D/E Ratio
0.00x88.9
Current Ratio
2.31x44.6
Value
37
P/E (TTM)
27.0x44.7
EV/EBITDA
19.9x34.4
P/FCF
—N/A
P/B
3.9x36.7
P/S
2.8x58.5
Div Yield
0.9%26.8
Momentum
40
52W High %
64%39.9
RS 6M
-5%59.3
SMA 50/200
0.91x34.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-48%11.0
FUNDAMENTALS
Market Cap
$153M
P/E (Forward)
—
Gross Margin
51.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AMRUTANJAN.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AMRUTANJAN.NS | Amrutanjan Health Care Limited(you) | $153M | 53 | Hold |
| BAJAJHCARE.NS | Bajaj HealthCare Limited | $120M | 59 | Hold |
| THEMISMED.NS | Themis Medicare Limited | $129M | 62 | Hold |
| INDOCO.NS | Indoco Remedies Limited | $237M | 57 | Hold |
| SIGACHI.NS | Sigachi Industries Limited | $140M | 39 | Hold |
| BAFNAPH.NS | Bafna Pharmaceuticals Limited | $77M | 55 | Hold |
| KILITCH.NS | Kilitch Drugs (India) Limited | $69M | 58 | Hold |
| SHUKRAPHAR.NS | Shukra Pharmaceuticals Limited | $252M | 38 | Hold |
| BETA.NS | Beta Drugs Limited | $228M | 72 | Buy |
| WANBURY.NS | Wanbury Limited | $91M | 69 | Buy |
Peer medians: ROE 11.8% · P/E 42.8x · Gross margin 59.4%